Anti-Inflammatory Effect of Pirfenidone in the Bleomycin-Hamster Model of Lung Inflammation
- 1 January 2000
- journal article
- Published by Springer Nature in Inflammation
- Vol. 24 (5) , 477-491
- https://doi.org/10.1023/a:1007068313370
Abstract
We have previously reported the antifibrotic effects of pirfenidone (PD) in the bleomycin (BL)-hamster model of lung fibrosis. Since the development of fibrosis is generally preceded by acute lung...Keywords
This publication has 45 references indexed in Scilit:
- Messages and handshakes: cellular interactions in pulmonary fibrosisPathology, 1995
- Enhanced IL-1 beta and tumor necrosis factor-alpha release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure.The Journal of Immunology, 1993
- Pathogenesis of Pulmonary Fibrosis in Interstitial Lung Disease: Alveolar Macrophage PDGF(B) Gene Activation and Up-regulation by Interferon GammaAmerican Review of Respiratory Disease, 1991
- Quantification of Cells Recovered by Bronchoalveolar Lavage: Comparison of Cytocentrifuge Preparations with the Filter MethodAmerican Review of Respiratory Disease, 1988
- Transforming growth factor type beta induces monocyte chemotaxis and growth factor production.Proceedings of the National Academy of Sciences, 1987
- Current concepts of the pathogenesis of fibrosis: lessons from pulmonary fibrosis.1984
- Pulmonary Fibrosis—A possible mechanismToxicology and Applied Pharmacology, 1979
- Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage.1979
- Bronchoalveolar Lavage in Interstitial Lung DiseaseAnnals of Internal Medicine, 1978
- CHRONIC INTERSTITIAL PULMONARY FIBROSIS PRODUCED IN HAMSTERS BY ENDOTRACHEAL BLEOMYCIN - LUNG-VOLUMES, VOLUME-PRESSURE RELATIONS, CARBON-MONOXIDE UPTAKE, AND ARTERIAL BLOOD-GAS STUDIESPublished by Elsevier ,1978